Paradigm Health has partnered with Sheba Medical Center, Israel's largest hospital, and its innovation arm, ARC Innovation, to establish a global network for clinical research.

The collaboration aims to revolutionize clinical trials by utilizing Paradigm's AI-driven platform to automate processes, enhance site selection, and improve patient recruitment and retention. The partnership seeks to make trials more accessible, efficient and patient-centered by moving them closer to patients' homes, potentially reducing costs and accelerating the development of new therapies.

Sheba and ARC plan to expand the clinical trial platform to their global ecosystem of hospitals, standardizing methodologies and improving access to innovative treatments. They aim to become one of the world's first fully integrated AI-based hospitals.

Analyst QuickTake: This marks the second international partnership Paradigm Health has secured in 2024. In August 2024, the company partnered with Fujitsu to enhance clinical trials and tackle drug loss in Japan. Additionally, earlier this month , Paradigm partnered with Florida Cancer Specialists to expand clinical trial access.